|
| Catalog Number | Size | Price (USD) | Shopping Cart |
|---|---|---|---|
| MO15120 | 100 ug | $255.00 | Buy Now | Add to Cart |

Extracellular signal-regulated kinase 3 (ERK3) is a serine/threonine protein kinase also known as mitogen-activated protein kinase 6 (MAPK6) and p97MAPK. Unlike ERK1 and ERK2, ERK3 lacks the phosphoacceptor sequence T-E-Y in its activation loop. This kinase also possesses a unique C-terminal extension that is missing in traditional MAPKs. Highly unstable, ERK3 is rapidly degraded following N-terminal ubiquitination.
ERK3 is involved in various cellular proliferation, differentiation, and cell cycle progression in response to a variety of extracellular signals making it useful for the study of processes like angiogenesis, neurogenesis and tumorigenesis. The activation of ERK by proinflammatory stimuli may play important roles in innate immune responses and autoimmunity.
Image: Extracellular signal-regulated kinase 3 (ERK3) staining of paraffin-embedded human breast cancer tissue sections using 8 µg/mL mouse anti-human ERK3 monoclonal antibody. Tissues were stained using anti-mouse HRP-DAB (brown) and counterstained with haematoxylin (blue).
More Links:
![Picture[2]](/site/special/A8x67cex66x1.jpg)
Image: Detection of ERK3. Lysate from human U937 cells was resolved by SDS-PAGE, transferred to an Immobilon-P membrane, and immunoblotted with 1 μg/mL mouse anti-ERK3, as described in Protocol on Datasheet. A 15 second exposure to film is shown.














